Muggia, Italy

Paolo Gambini


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Paolo Gambini in Pharmaceutical Compositions

Introduction

Paolo Gambini, an inventive mind from Muggia, Italy, has made significant strides in the field of pharmaceuticals. With a focus on creating advanced drug delivery systems, his work has contributed to the ongoing evolution of pharmaceutical technology.

Latest Patents

Gambini holds a notable patent titled "Pharmaceutical compositions in form of polymeric microparticles obtained by extrusion and spheronization." This innovative process involves the preparation of pharmaceutical compositions utilizing one or more polymers in combination with one or more drugs through the extrusion and spheronization technique. Notably, the polymers used within this patent are classified as cross-linked amphiphilic polymers, which serve as a pivotal element in enhancing the effectiveness of drug delivery.

Career Highlights

Currently, Gambini is employed at Eurand International S.p.A., where he leverages his expertise and experience to advance the field of pharmaceutical innovations. His role at the company underscores his commitment to developing impactful solutions that enhance patient outcomes through innovative drug formulations.

Collaborations

Throughout his career, Paolo Gambini has collaborated with a remarkable team, including colleagues Fabio Carli and Massimo Bresciani. These collaborations have enabled him to share knowledge and drive forward innovative projects within the pharmaceutical industry, ultimately leading to meaningful advancements in drug delivery systems.

Conclusion

Paolo Gambini's contributions to the pharmaceutical sector highlight the importance of innovation in improving healthcare solutions. His patent and ongoing work underscore his role as an influential inventor in the realm of pharmaceutical compositions, fostering developments that hold the potential to enhance the effectiveness of medications for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…